1 Mid-Cap Stock with Exciting Potential and 2 Facing Challenges
5 Insightful Analyst Questions From Charles River Laboratories’s Q2 Earnings Call
September Nasdaq 100 E-Mini futures (NQU26) are down -0.42% this morning as concerns about the AI trade linger after forecasts from Western Digital and Sandisk fell short of investors’ lofty expectations....
CRL Q2 Deep Dive: Strategic Portfolio Moves and Biopharma Demand Fuel Margin Expansion
The S&P 500 Index ($SPX ) (SPY ) on Wednesday closed down -0.17%, the Dow Jones Industrial Average ($DOWI ) (DIA ) closed up +0.49%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.83%. September...
The S&P 500 Index ($SPX ) (SPY ) today is up +0.31%, the Dow Jones Industrial Average ($DOWI ) (DIA ) is up +1.05%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.03%. September E-mini S&P futures...
Charles River Laboratories’s (NYSE:CRL) Q2 CY2026 Sales Top Estimates, Stock Soars
Charles River Laboratories International, Inc. (NYSE: CRL) today reported its results for the second quarter ended June 27, 2026. Key Highlights ...
Barchart Research What to Expect from CRL Earnings CRL Generated August 4, 2026 Current Price $234.12 EPS Estimate $$2.72 Consensus Rating Moderate Buy Average Move 8.50% Charles River Laboratories: When...